ANGIOLINE COMPANY BECAME SPONSOR OF VI ANNUAL PRACTICAL CONFERENCE ON URGENT ISSUES OF INTERVENTIONAL RADIOLOGY IN ST. PETERSBURG
St. Petersburg, 23/10/2015. ANGIOLINE Company became the sponsor of the VI Annual Practical Conference with international participation on Urgent Issues of Interventional Radiology arranged by the non-government organization Interventional Radiology of the North-Western Region in St. Petersburg. To support the event, the Company is involved in the exhibition within the framework of the Conference and will participate in the discussion on the peculiarities of using drug-eluting stents.
“The support of Russian Conferences is among our priorities”, said Andrey Kudryashov, President of ANGIIOLINE. “It is precisely these events that are one of the most effective mechanisms for development of the domestic market of pharmaceuticals and medical devices. For us, reports of Russian practitioners and invited world-known scientists mean information on possible clinical cases which must be considered in the production of our stents first of all”.
About ANGIOLINE Company
ANGIOLINE Company is one of the key Russian developers and manufacturers of medical devices, namely: coronary stents and catheters for rendering medical aid to the patients with ischemic heart disease. The range of products contains over 15 items of medical devices. Currently, the company’s devices are used in more than 60 medical and preventive treatment institutions from 37 regions of the Russian Federation. For the period from 2010 to 2015, more than 35 thousand stent placement surgeries were performed using ANGIOLINE products. As of the end of 2014, ANGIOLINE’s share of the stent market in Russia is about 10%. Meanwhile, the production capacities allow at least five-fold increase in the coronary stent output. The company’s manufacturing facilities are located in Novosibirsk, in the industrial park of Akademgorodok. Further information about the Company is available at the following Internet address: http://www.angioline.ru